DAFNA Capital Management’s Acrivon Therapeutics ACRV Stock Holding History

DAFNA Capital Management’s Portfolio ACRV Stock Details ACRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$677K	Hold
2024 Q3	$787K	Sell
2024 Q2	$704K	Sell
2024 Q1	$939K	Hold
2023 Q4	$646K	Buy
2023 Q3	$735K	Hold
2023 Q2	$996K	Buy
2023 Q1	$649K	Buy
2022 Q4	$180K	Buy